Latest Breaking News On - Bayhill therapeutics inc - Page 1 : vimarsana.com

BioSpace Movers & Shakers, April 9

BioSpace Movers & Shakers, April 9
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Stanford universityUnited statesSan franciscoLibbie mansellLee shapiroDavid rubinJamie krauseGoldman sachsPenrose therapeutxDinesh kapurSrikantan nagarajanMuzammil mansuriJohn robinsonRichard brycePamela tenaertsMichael spigarelli

BioSpace Movers & Shakers, April 9

Published: Apr 09, 2021 By Alex Keown Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East. PsyBio Therapeutics – Michael Spigarelli was named chief medical officer of Ohio-based PsyBio. Before PsyBio Therapeutics, Spigarelli served as CMOr for Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases. Prior to that, he served as Vice President of Medical Affairs for Immucor, Inc., a leading provider of transfusion and tran

Stanford universityUnited statesSan franciscoLibbie mansellLee shapiroDavid rubinJamie krauseGoldman sachsPenrose therapeutxDinesh kapurSrikantan nagarajanMuzammil mansuriJohn robinsonRichard brycePamela tenaertsMichael spigarelli

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Stanford universityUnited statesCalifornia institute of technologyLos angelesEllen roseJennifer zibudaHideki garrenRoche neuroimmunologyNovartis pharmaRoche ltdUniversity of californiaHead of communicationsInvestor relations communicationsRoche genentech incBayhill therapeutics incProthena corporation

Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer

Share: DUBLIN, Ireland, April 05, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced the appointment of Hideki Garren, MD, PhD, as Chief Medical Officer. Dr. Garren will lead the clinical and medical organizations to advance Prothena s clinical pipeline. Hideki brings valuable experience and expertise to our team as we look ahead towards transitioning to a fully integrated research, development and commercial biotechnology company, said Gene Kinney, PhD, President and Chief Executive Officer. His experience leading several late-stage development programs in neurology and rare disease indications through registration and launch is particularly relevant as we advance our pipeline of programs in these areas. We are delighted to welcome him to the team as we prepare for our next

Stanford universityUnited statesCalifornia institute of technologyLos angelesEllen roseHideki garrenJennifer zibudaRoche neuroimmunologyNovartis pharmaUniversity of californiaRoche ltdHead of communicationsInvestor relations communicationsRoche genentech incBayhill therapeutics incProthena corporation